Thank you very much. I'm sorry to interrupt you, but I don't have much time left.
We agree on the importance of evidence. Let's take the example of carrots, which is very easy to understand. The formulation for linuron was altered, and that new formulation was not yet registered for use in Canada, but it was in the United States. Our producers couldn't use it. So we almost ended up in a situation where we would have imported carrots grown using a product that was not registered here, which would have put our producers at a disadvantage. Again last summer, an overwhelming quantity of carrots from China entered Canada, whereas they were banned in the United States, to protect farmland. There are a lot of examples, and I agree with what both of you are saying. Evidence is needed.
Then there is a sub-question related to authorization for use. Since Canada's market is smaller than the markets of our trading partners, international companies don't come and invest here, first and foremost, to get their products approved in Canada. Instead, they will have them authorized for use in Europe or the United States. This is a problem for Canada.
Do you think it is possible to establish international collaboration, without reducing quality standards, in order to share the authorization steps with a number of partners?
The question is for both of you.